Skip to Content


In the US, Tirofiban (tirofiban systemic) is a member of the drug class glycoprotein platelet inhibitors and is used to treat Acute Coronary Syndrome.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antiplatelet agent: Glycoprotein IIb/IIIa-receptor antagonist

Chemical Name

Tyrosine, N-(butylsufonyl)-O-[4-(4-piperidinyl)butyl]-

Foreign Names

  • Tirofibanum (Latin)
  • Tirofiban (German)
  • Tirofiban (French)
  • Tirofiban (Spanish)

Generic Names

  • Tirofiban (OS: BAN, DCF)
  • Tirofiban hydrochlorid anhydrat (IS)
  • Tirofiban Hydrochloride Anhydrous (IS)
  • Tirofiban Hydrochloride (OS: USAN, BANM)
  • L 700462 (IS)
  • MK 383 (IS)
  • Tirofiban hydrochlorid-1-Wasser (IS)
  • UNII-6H925F8O5J (IS)

Brand Names

  • Aggrastat
    Iroko Cardio, Malta; Merck Sharp & Dohme, Lebanon
  • Tirofiban Beacon
    Beacon Pharmaceuticals, United Kingdom
  • Tirofuse
    Lupin, India
  • Tirozest
    Biocon, India
  • Trombopriv
    Via Pharma, Lithuania
  • Xtraban
    Ranbaxy, India
  • Aggrastat
    Iroko, Egypt; A. Menarini, Singapore; Aspen, Malaysia; Aspen, New Zealand; Aspen, Philippines; Chiesi, Turkey; Correvio, Austria; Correvio, Switzerland; Correvio, Cyprus; Correvio, Germany; Correvio, Malta; Correvio, Netherlands; Correvio UK, United Kingdom; Eumedica, Belgium; Iroko, China; Iroko, Estonia; Iroko Cardio, Australia; Iroko Cardio, Lithuania; Medicure, United States; Merck Sharp & Dohme, Bulgaria; Merck Sharp & Dohme, Hong Kong; Merck Sharp & Dohme, Israel; Merck Sharp & Dohme, Latvia; Merck Sharp & Dohme, Pakistan; Merck Sharp & Dohme, Serbia; Merck Sharp & Dohme, Taiwan; MSD, India; Orion, China; Orion, Serbia; Vianex, Greece
  • Aggrastet
    Pharmacare, South Africa
  • Aggribloc
    AHPL, India
  • Agrastat
    Aspen Labs, Mexico; Biotoscana, Colombia; Biotoscana Farma, Chile; Correvio, France; Iroko Pharmaceuticals, Spain; Merck Sharp & Dohme, Brazil; Merck Sharp & Dohme, Ecuador; Merck Sharp & Dohme, Venezuela
  • Tirofiban HEXAL
    Hexal, Germany
  • Tirofiban Medac
    medac, France
  • Tirofiban-XinShiDai Pharm
    XinShiDai Pharmaceutical, China
  • Trombopriv
    Via Pharma, Estonia
  • Xin Wei Ning
    Grand Pharmaceutical Group, China


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.